An innovation in glioma treatment, this product utilizes Temozolamide, an effective chemotherapeutic drug, enhanced with Sulfobutyl Beta Cyclodextrin Sodium for increased solubility and stability. The reformulation ensures High Solubility and Improved Stability for a reliable shelf life, while an Enhanced Dissolution Rate eliminates re-filtering needs, saving time for healthcare professionals. With a Enhanced Safety Profile due to rigorous quality control measures, this treatment option is safer for patients
The Sulfobutyl Beta Cyclodextrin Sodium-Temozolamide Injection provides an innovative approach to glioma treatment. Infused with Temozolamide, this formula is a potent weapon against central nervous system tumors, particularly malignant gliomas.
This medical masterpiece is designed with meticulous precision. The many features of this product include:
With a production capacity scaling up to 1,000,000kg monthly, we can meet your demand anywhere around the globe. The specially designed injectable-grade product is available in customizable options of 500g/bag, 1kg/bag, 10kg/drum, or 20kg/drum to accommodate your specific needs. Embrace the new standard in glioma treatment with our Sulfobutyl Beta Cyclodextrin Sodium-Temozolamide Injection.